Acute Effects of Blackcurrant and Citrus Polyphenol Extracts on Postprandial Glycaemia

NCT03184064 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2018-08-22

No results posted yet for this study

Summary

Large postprandial glucose responses are associated with increased risk of chronic diseases, including diabetes and cardiovascular disease. Our group have previously shown that fruit polyphenol extracts, when consumed immediately before a mixed carbohydrate meal, reduce postprandial glycaemia. The aim of this study is to investigate the effects of a blackcurrant polyphenol extract and citrus polyphenol extract (and their combination), on postprandial glycaemia, insulinaemia and gastrointestinal hormone concentrations following a mixed carbohydrate test meal. It is hypothesised that blackcurrant and citrus extracts alone will inhibit glycaemia compared to placebo, and a combination of the two will have a greater effect.

Conditions

  • Postprandial Period

Interventions

DIETARY_SUPPLEMENT

Blackcurrant extract (low dose)

Participants will consume a small beverage that contains blackcurrant extract (low dose) immediately before a high-carbohydrate meal.

DIETARY_SUPPLEMENT

Placebo

Participants will consume a small beverage that contains no fruit extracts immediately before a high-carbohydrate meal.

DIETARY_SUPPLEMENT

Citrus extract (low dose)

Participants will consume a small beverage that contains citrus extract (low dose) immediately before a high-carbohydrate meal.

DIETARY_SUPPLEMENT

Blackcurrant extract (high dose)

Participants will consume a small beverage that contains blackcurrant extract (high dose) immediately before a high-carbohydrate meal.

DIETARY_SUPPLEMENT

Blackcurrant and citrus extracts (low dose / low dose)

Participants will consume a small beverage that contains blackcurrant and citrus extracts (low dose / low dose)immediately before a high-carbohydrate meal.

Sponsors & Collaborators

Principal Investigators

  • Wendy L Hall, PhD · King's College London

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-30
Primary Completion
2018-02-01
Completion
2018-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03184064 on ClinicalTrials.gov